FDA warns public against counterfeit pain reliever

THE Food and Drug Administration (FDA) yesterday warned the public against buying and using a counterfeit version of a popular pain reliever medicine.

In its Advisory No. 2024-1000, the FDA said the public should be vigilant against the counterfeit version of Alaxan®FR (generic name: Ibuprofen + Paracetamol) 200 mg/ 325 mg Capsule.

“All healthcare professionals and the general public are hereby warned as to the availability of this counterfeit drug product in the market,” said the FDA.

“The lot number, capsule, knurling, and print appearance are not comparable with the standard features of the registered product,” it said.

The agency said consuming counterfeit drugs carry possible health risks.

It also reminded drug stores that the selling or offering for sale of counterfeit drugs violate the Food and Drug Administration Act of 2009, and the special law on counterfeit drugs.

“Anyone found selling the said counterfeit drug product will be penalized,” it said.

The FDA called on all local government units and law enforcement agencies to ensure that the counterfeit product is not sold or made available in their localities.